Phase 2 Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)
Attention Deficit Hyperactivity Disorder (ADHD)
Universidade do Sul de Santa Catarina60 enrolled1 locationNCT07592390
Recruiting
Phase 2
Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression
Depression - Major Depressive DisorderAttention Deficit Hyperactivity Disorder (ADHD)
Prof. Dr. Frank Behrens105 enrolled2 locationsNCT06967857
Recruiting
Phase 2Phase 3
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.315 enrolled1 locationNCT07086313
Recruiting
Phase 2Phase 3
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.630 enrolled1 locationNCT06931080
Recruiting
Phase 2
The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Bazelet Nehushtan LtD.120 enrolled1 locationNCT06542445
Recruiting
Phase 2
An Investigation of Chiropractic NET for Attention Deficit Hyperactivity Disorder in Children.
Attention Deficit Hyperactivity Disorder (ADHD)
Dr Henry Pollard (Primary Supervisor, Director of Research- Dept Health & Chiropractic Macquarie University)93 enrolled1 locationACTRN12606000332527